Kuchinad Kamini E, Hutton Heidi E, Monroe Anne K, Anderson Garrick, Moore Richard D, Chander Geetanjali
Department of General Internal Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.
University of Maryland School of Medicine, Baltimore, MD, USA.
BMC Res Notes. 2016 Apr 22;9:229. doi: 10.1186/s13104-016-2032-4.
Persons living with HIV (PLWH) and substance use/misuse experience significant barriers to engagement in HIV care at every step of the HIV care continuum including: (1) HIV testing and diagnosis (2) linkage to clinical care (3) retention in care pre-antiretroviral therapy (ART) (4) ART initiation and adherence (5) viral suppression. We qualitatively explored the facilitators of and barriers to participation in the HIV care continuum among PLWH with substance use/misuse.
We performed semi-structured in-depth interviews with 34 PLWH in care with recent substance use. The transcripts were analyzed in an iterative process using an editing style analysis. Interviews were conducted until thematic saturation was achieved.
Participants attributed an escalation in drug use at the time of diagnosis to denial of their disease and the belief that their death was inevitable and cited this as a barrier to treatment entry. In contrast, participants reported that experiencing adverse physical effects of uncontrolled HIV infection motivated them to enroll in care. Reported barriers to retention and adherence to care included forgetting medications and appointments because of drug use, prioritizing drug use over HIV treatment and side effects associated with medications. Participants described that progression of illness, development of a medication taking ritual and a positive provider-patient relationship all facilitated engagement and reengagement in care.
PLWH with substance use engaged in care describe barriers to and facilitators of optimal engagement related to and distinct from substance use. Greater understanding of the biologic, psychological and social factors that promote and impair engagement in care can inform interventions and reduce the increased morbidity and mortality experienced by PLWH with substance use.
艾滋病毒感染者(PLWH)以及存在药物使用/滥用问题的人在艾滋病毒治疗连续统一体的每一个环节都面临着参与艾滋病毒护理的重大障碍,包括:(1)艾滋病毒检测与诊断;(2)与临床护理的衔接;(3)在抗逆转录病毒疗法(ART)前保持护理连续性;(4)开始ART并坚持治疗;(5)病毒抑制。我们定性地探讨了存在药物使用/滥用问题的艾滋病毒感染者参与艾滋病毒护理连续统一体的促进因素和障碍。
我们对34名近期有药物使用情况的接受护理的艾滋病毒感染者进行了半结构化深度访谈。使用编辑风格分析法对访谈记录进行迭代分析。访谈持续进行直至达到主题饱和。
参与者将诊断时药物使用的增加归因于对自身疾病的否认以及认为自己的死亡不可避免,并将此视为接受治疗的障碍。相比之下,参与者报告称,未得到控制的艾滋病毒感染所带来的不良身体影响促使他们接受护理。报告的保持护理连续性和坚持治疗的障碍包括因药物使用而忘记服药和预约、将药物使用置于艾滋病毒治疗之上以及药物相关的副作用。参与者描述称,疾病进展、养成服药习惯以及积极的医患关系都促进了对护理的参与和重新参与。
有药物使用问题且参与护理的艾滋病毒感染者描述了与药物使用相关和不同的最佳参与护理的障碍和促进因素。对促进和损害护理参与的生物学、心理和社会因素有更深入的了解可为干预措施提供信息,并降低有药物使用问题的艾滋病毒感染者所经历的发病率和死亡率的增加。